FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Commercial · sales Supplies 12 medicines in Korea and launched a CAR-T therapy there in 2026.

  • At its 15th-anniversary briefing it said it had 95 employees in Korea as of June 2026, about 40% in R&D-related roles. Source

Roles often seen at this stageSales & marketing · Medical & MSL · Regulatory affairs

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-18

Gilead Sciences Korea

The Korean unit of Gilead Sciences, founded in 2011, which supplies 12 medicines in Korea across liver disease, HIV, antifungal and oncology.

Yescarta

Marketed

A CAR-T therapy for relapsed or refractory diffuse large B-cell lymphoma and related lymphomas, launched in Korea in June 2026 as a non-reimbursed product.

Trodelvy

Marketed

An antibody-drug conjugate for triple-negative breast cancer, covered by national health insurance for third-line or later treatment from June 2025.

Completion reported

Launched the CAR-T therapy Yescarta in Korea as a non-reimbursed product and is pursuing reimbursement listing.

Completion reported

Trodelvy gained national health insurance coverage for third-line or later triple-negative breast cancer.

Official role guide

Gilead Sciences Korea careers

Current availability unconfirmed

Observed 2026-11-18

Work
Unconfirmed — The official careers page was found, but postings and duties were not read in this check.
Experience & requirements
Unconfirmed — Requirements were not checked on the official careers page.

Information from a role guide does not establish a current vacancy.

Sources & coverage 4

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 창립 15주년 맞은 길리어드 사이언스 코리아 …"치료 넘어 환자의 삶까지 혁신" ↗알파경제 · Published 2026-09-22 · Sources checked 2026-11-18 · Original unavailable
  2. 길리어드코리아, 국내 진출 15년…12개 치료제 공급하며 항암·염증으로 영역 확대 ↗팍스메디컬뉴스 · Published 2026-09-22 · Sources checked 2026-11-18 · Original unavailable
  3. 높은 ICER값으로 고생한 ADC 치료제 '트로델비', 내달 급여등재 ↗히트뉴스 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable
  4. 길리어드 사이언스 코리아 채용 ↗Gilead Sciences · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable